Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:NTBL

Notable Labs (NTBL) Stock Price, News & Analysis

Notable Labs logo

About Notable Labs Stock (NASDAQ:NTBL)

Advanced Chart
Remove Ads

Key Stats

Today's Range
N/A
50-Day Range
$0.24
$0.48
52-Week Range
N/A
Volume
2.11 million shs
Average Volume
1.01 million shs
Market Capitalization
$2.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00
Consensus Rating
Moderate Buy

Company Overview

Notable Labs, Ltd., a clinical-stage platform therapeutics company, develops predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient will clinically respond to their actual treatment. Its PPMP is designed to identify and select clinically responsive patients prior to their treatment and enables fast-track therapeutic development in this patient population. The company's pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor to induce cell cycle arrest and apoptosis in various cancer cells; and Fosciclopirox, a pro-drug of ciclopirox for acute myeloid leukemia. Notable Labs, Ltd. was incorporated in 2014 and is headquartered in Foster City, California.

Remove Ads
Receive NTBL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Notable Labs and its competitors with MarketBeat's FREE daily newsletter.

NTBL Stock News Headlines

Notable Labs, Ltd. (NTBLQ)
Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Notable Labs (NTBL) was downgraded to a Hold Rating at JMP Securities
Notable Labs Announces CEO Transition
See More Headlines

NTBL Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Notable Labs investors own include Algonquin Power & Utilities (AQN), LiveOne (LVO), Palatin Technologies (PTN), Frontier Group (ULCC), Adverum Biotechnologies (ADVM), Sirius XM (SIRI) and Clearside Biomedical (CLSD).

Company Calendar

Today
4/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:NTBL
Previous Symbol
NASDAQ:NTBL
Employees
40
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$7.00
High Stock Price Target
$9.00
Low Stock Price Target
$5.00
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-11,260,000.00
Pretax Margin
-3,368.05%

Debt

Sales & Book Value

Annual Sales
$313,000.00
Price / Cash Flow
N/A
Book Value
$6.81 per share
Price / Book
N/A

Miscellaneous

Free Float
9,544,000
Market Cap
$2.24 million
Optionable
No Data
Beta
0.98
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report

This page (NASDAQ:NTBL) was last updated on 4/7/2025 by MarketBeat.com Staff
From Our Partners